Effects of prescription adaptation by pharmacists

BMC Health Services Research

Volumn 10, Issue , 2010, Pages

  Law, Michael R ^a   Morgan, Steven G ^a   Majumdar, Sumit R ^b   Lynd, Larry D ^a   Marra, Carlo A ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANADA; COHORT ANALYSIS; DRUG UTILIZATION; FEMALE; HEALTH CARE POLICY; HUMAN; LEGAL ASPECT; MALE; MANAGEMENT; PHARMACIST; PHARMACY; PRESCRIPTION; PROFESSIONAL PRACTICE; PROFESSIONAL STANDARD; RISK ASSESSMENT; STANDARD; STATISTICS;

BRITISH COLUMBIA; COHORT STUDIES; COMMUNITY PHARMACY SERVICES; DRUG PRESCRIPTIONS; DRUG UTILIZATION; FEMALE; HEALTH CARE REFORM; HUMANS; MALE; PHARMACISTS; POLICY MAKING; PROFESSIONAL AUTONOMY; PROFESSIONAL ROLE; RISK ASSESSMENT;

EID: 78349269569     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-10-313     Document Type: Article

References (37)

1. Capitation and enhanced fee-for-service models for primary care reform: a population-based evaluation. RH Glazier J Klein-Geltink A Kopp LM Sibley, CMAJ 2009 180 72 81 19468106
2. Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns. N Nkansah O Mostovetsky C Yu T Chheng J Beney CM Bond L Bero, Cochrane Database of Systematic Reviews The Cochrane Collaboration, Bero L Chichester, UK: John Wiley & Sons, Ltd 2010
3. Prescribing by pharmacists in Alberta. N Yuksel G Eberhart TJ Bungard, Am J Health Syst Pharm 2008 65 2126 2132 10.2146/ajhp080247 18997141
4. Pharmacist prescribing in the UK - a literature review of current practice and research. AP Tonna D Stewart B West D McCaig, J Clin Pharm Ther 2007 32 545 556 10.1111/j.1365-2710.2007.00867.x 18021331
5. Stakeholders' views of UK nurse and pharmacist supplementary prescribing. R Cooper C Anderson T Avery P Bissell L Guillaume A Hutchinson J Lymn E Murphy J Ratcliffe P Ward, J Health Serv Res Policy 2008 13 215 221 10.1258/jhsrp.2008.008004 18806179
6. Learning to prescribe - pharmacists' experiences of supplementary prescribing training in England. RJ Cooper J Lymn C Anderson A Avery P Bissell L Guillaume A Hutchinson E Murphy J Ratcliffe P Ward, BMC Med Educ 2008 8 57 10.1186/1472-6920-8-57 19061487
7. Opportunity or threat? General practitioner perceptions of pharmacist prescribing. A Blenkinsopp J Tann A Evans J Grime, International Journal of Pharmacy Practice 2008 16 29 34 10.1211/ijpp.16.1.0006 (Pubitemid 351216994)
8. The Canadian Rx Atlas. S Morgan C Raymond D Mooney D Martin, Vancouver, BC: Centre for Health Services and Policy Research, University of British Columbia 2008
9. Health Care in Canada. Canadian Institute for Health Information, Ottawa, Ontario: Cana 2008
10. Adherence to Medication. L Osterberg T Blaschke, N Engl J Med 2005 353 487 497 10.1056/NEJMra050100 16079372
11. Attaining pharmacist recognition in the United States. B Meyer J Hill G Trujillo, Am J Health Syst Pharm 2008 65 2152 2153 10.2146/ajhp080515 18997146
12. Orientation Guide - Medication Management (Adapting a Prescription). http://www.bcpharmacists.org/library/D-Legislation-Standards/ D-2-Provincial-Legislation/1017-PPP58-OrientationGuide.pdf
13. Most Routine Prescriptions Now Easier to Renew. http://www2.news.gov.bc. ca/news-releases-2005-2009/2008HSERV0120-001939.htm
14. Opportunities and responsibilities in pharmaceutical care. C Hepler L Strand, Am J Health Syst Pharm 1990 47 533 543
15. Population by year, by province and territory. http://www40.statcan.gc. ca/l01/cst01/DEMO02A-eng.htm
16. Population of census metropolitan areas (2006 Census boundaries). http://www40.statcan.gc.ca/l01/cst01/demo05a-eng.htm
17. Population by sex and age group, by province and territory. http://www40.statcan.gc.ca/l01/cst01/demo31d-eng.htm
18. Population by selected ethnic origins, by province and territory (2006 Census). http://www40.statcan.gc.ca/l01/cst01/demo26k-eng.htm
19. National Health Expenditure Trends: 1975 to 2009. Canadian Institute for Health Information, Ottawa, Ontario: Canadian Institute for Health Information 2009
20. Drug Expenditure in Canada. Canadian Institute for Health Information, Ottawa, Ontario: Canadian Institute for Health Information 2009
21. S Morgan GE Hanley C Cunningham D Mooney, BC Rx Atlas Vancouver, BC: Centre for Health Services and Policy Research, University of British Columbia 2 2009
22. Outcomes of Reference Pricing for Angiotensin-Converting-Enzyme Inhibitors. S Schneeweiss AM Walker RJ Glynn M Maclure C Dormuth SB Soumerai, N Engl J Med 2002 346 822 829 10.1056/NEJMsa003087 11893794
23. Impact of reference-based pricing of nitrates on the use and costs of anti-anginal drugs. PV Grootendorst LR Dolovich BJ O'Brien AM Holbrook AR Levy, CMAJ 2001 165 1011 1019 11699696
24. Canadian Taxfiler. http://www.statcan.gc.ca/bsolc/olc-cel/olc-cel?catno= 17C0010&lang=eng
25. On the validity of area-based income measures to proxy household income. G Hanley S Morgan, BMC Health Services Research 2008 8 79 10.1186/1472-6963-8-79 18402681
26. S Morgan GE Hanley C Cunningham D Mooney, BC Rx Atlas Vancouver, BC: Centre for Health Services and Policy Research, University of British Columbia 2 2009
27. The ATC/DDD System. http://www.whocc.no/atcddd/
28. Impact of reference-based pricing for histamine-2 receptor antagonists and restricted access for proton pump inhibitors in British Columbia. JK Marshall PV Grootendorst BJ O'Brien LR Dolovich AM Holbrook AR Levy, CMAJ 2002 166 1655 1662 12126319
29. Impact of reference-based pricing of nitrates on the use and costs of anti-anginal drugs. PV Grootendorst LR Dolovich BJ O'Brien AM Holbrook AR Levy, CMAJ 2001 165 1011 1019 11699696
30. Outcomes of Reference Pricing for Angiotensin-Converting-Enzyme Inhibitors. S Schneeweiss AM Walker RJ Glynn M Maclure C Dormuth SB Soumerai, N Engl J Med 2002 346 822 829 10.1056/NEJMsa003087 11893794
31. Socio-Economic Profiles, by LHA. http://www.bcstats.gov.bc.ca/data/sep/ lha/lha-main.asp
32. R Reid L MacWilliam N Roos B Bogdanovic C Black, Measuring Morbidity in Populations: Performance of the Johns Hopkins Adjusted Clinical Group (ACG) Case-mix Adjustment System in Manitoba Winnepeg, Manitoba: Manitoba Centre for Health Policy and Evaluation, Dept. of Community Health Services, Faculty of Medicine 1999
33. Segmented regression analysis of interrupted time series studies in medication use research. A Wagner S Soumerai F Zhang D Ross-Degnan, J Clin Pharm Ther 2002 27 299 309 10.1046/j.1365-2710.2002.00430.x 12174032
34. Methods for estimating confidence intervals in interrupted time series analyses of health interventions. F Zhang A Wagner S Soumerai D Rossdegnan, Journal of Clinical Epidemiology 2009 62 143 148 10.1016/j.jclinepi.2008.08.007 19010644
35. Estimating Causal Effects from Large Data Sets Using Propensity Scores. DB Rubin, Annals of Internal Medicine 1997 127 757 763 9382394
36. Psychotropic medication use in Canada. CA Beck JVA Williams JL Wang A Kassam N El-Guebaly SR Currie CJ Maxwell SB Patten, Can J Psychiatry 2005 50 605 613 16276851
37. Needs, Gaps and Opportunities Assessment - Emerging Themes. Presentation at the Pharmaceutical Policy Research Collaboration meeting. S Morgan C Cunningham, Vancouver, BC 2009